US$ 28.53
tirzepatide give you diarrhea and Diarrhea: Managing This GLP-1 Side Effect Mounjaro Side Effects | Dealing
Description
Adults with overweight or obesity taking the once-weekly GIP/GLP-1 receptor agonist tirzepatide achieved a mean weight loss of at least 16% at 72 weeks, according to topline results from the SURMOUNT-1 clinical trial

Think extra servings of lean protein, sweet potatoes, and fruits, not pizza and ice cream

Specific protocols for different weight gain patterns Not all weight gain looks the same
This is not hypothetical

Theyll create a plan thats personalized for you

Building tolerance over time The immune system adapts
